Clinical efficacy and safety of robotic retroperitoneal lymph node dissection for testicular cancer: a systematic review and meta-analysis
BackgroundRetroperitoneal lymph node dissection (RPLND) is an effective treatment for testicular tumors. In recent years, with the development of robotics, many urological procedures performed via standard laparoscopy have been replaced by robots. Our objective was to compare the safety and efficacy...
Main Authors: | Yacheng Yuan, Dawei Zhang, Yiping Ning, Hengfeng Luo, Xiaolong Qiu, Yangyang Tan, Yuxiang Li, Xukai Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1257528/full |
Similar Items
-
Twenty Years’ Experience in Retroperitoneal Lymph Node Dissection for Testicular Cancer in a Tertiary Referral Center
by: Angelo Mottaran, et al.
Published: (2023-01-01) -
Robotic-assisted retroperitoneal lymph node dissection for stage II testicular cancer
by: George McClintock, et al.
Published: (2024-01-01) -
Sperm telomere length as a novel biomarker of male infertility and embryonic development: A systematic review and meta-analysis
by: Yacheng Yuan, et al.
Published: (2023-01-01) -
Robot-assisted retroperitoneal lymph node dissection for post-chemotherapy residual mass in testicular cancer: Long-term experience from a tertiary care centre
by: Vivek Vasudeo, et al.
Published: (2023-01-01) -
A case of testicular cancer with retroperitoneal lymph node metastasis of teratoma with somatic‐type malignancy 18 years after initial treatment
by: Maiko Yamashita, et al.
Published: (2023-07-01)